908 Devices Inc. Q1 2025: Revenue Surges 59%, Reports Net Income of $43.6M, Adjusted EBITDA Loss Narrows to $4.6M

Reuters
05-13
<a href="https://laohu8.com/S/MASS">908 Devices Inc.</a> Q1 2025: Revenue Surges 59%, Reports Net Income of $43.6M, Adjusted EBITDA Loss Narrows to $4.6M

908 Devices Inc. (Nasdaq: MASS) reported its financial results for the first quarter of 2025, showing a significant increase in revenue from continuing operations, which grew 59% compared to the prior year. This growth was primarily driven by an increase in product and service revenue. The company's net income attributable to common stockholders reached $43.6 million for the first quarter, a notable improvement from a net loss of $10.9 million in the corresponding prior year period. This increase in net income was largely influenced by a $56.6 million gain from the divestiture of its bioprocessing product portfolio, despite a loss from discontinued operations during the first two months of the quarter. Operating expenses rose to $16.6 million, up from $11.5 million in the previous year, influenced by a $2.5 million non-cash charge related to the change in fair value of contingent consideration liability and expenses from the RedWave Technology acquisition. The adjusted EBITDA showed a loss of $4.6 million, an improvement from a $5.3 million loss in the same period last year. The company holds cash, cash equivalents, and marketable securities totaling $124.3 million as of March 31, 2025, with no outstanding debt. For the full year 2025, 908 Devices maintains its revenue guidance from continuing operations at $53 million to $55 million, representing an 11% to 15% growth compared to 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 908 Devices Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250513762831) on May 13, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10